Nitrous oxide
nitrous oxide
Overview
Nitrous oxide belongs to Dissociatives.
Effects
- A rapid, short-lived rush of euphoria, giddiness and uncontrollable laughter, with dissociation, dreamy detachment and a sense of floating.
- Distorted or echoing sound and vision, tingling, dizziness and heaviness of the body.
- Effects fade within about a minute. Repeated redosing brings headache, disorientation and, with heavy use, the numbness and unsteadiness of B12-related nerve damage.
Dosing & duration
Inhaled: medically as a metered gas mixed with oxygen. Recreationally from a balloon. There is no milligram 'dose'.. Not a recommendation. Nitrous oxide is inhaled, not dosed in milligrams, and the danger scales with how it is taken. NEVER inhale from a mask, tube or bag, or in a closed space (car, tent, sealed room). This displaces oxygen and causes asphyxia. Never inhale directly from a pressurised tank or charger (frostbite and lung injury). If used: sit down, use a single balloon at a time with normal air between breaths, keep sessions short and infrequent, and take vitamin B12: frequent heavy use is what causes the (sometimes permanent) nerve and spinal-cord damage.
Dose ranges
50% N₂O / 50% O₂, self-administered and titrated
A balloon filled from a charger, never a mask, and never straight from the tank
Duration
Seconds
≈1–2 min
Brief dizziness/headache. Nerve damage with heavy repeated use
Chemical & Physical Properties
| Formula | N2O |
| Molar mass | 44.01 g/mol |
| State | Gas |
| Melting point | -90.81 °C |
| Boiling point | -88.46 °C |
| Density | 1.266 g/cm³ at -89 °C (USCG, 1999) |
| Vapor pressure | 51.3 atm (NIOSH, 2024) |
| pKa | Not reported |
| LogP | 0.36 |
| Solubility | 0.1 % at 25 °C (NIOSH, 2024), Slightly soluble in water, At 20 °C and 2 atm one liter of the gas dissolves in 1.5 liters of water |
| Refractive index | 1.000516 at 0 °C (D line, 0.5893 µm, 1 atm) |
Identifiers & Synonyms
| CAS | 10024-97-2 |
| CAS (enantiomer) | |
| PubChem CID | 948 |
| InChIKey | GQPLMRYTRLFLPF-UHFFFAOYSA-N |
| InChI | InChI=1S/N2O/c1-2-3 |
| SMILES | [N-]=[N+]=O |
Synonyms
- Laughing gas
- Dinitrogen monoxide
- Nitrous
- N2O
- Whippits (misuse)
- Nos
- Nangs
- Whippits
Pharmacodynamics & Biochemistry
Nitrous oxide (N₂O, 'laughing gas') is an inhaled gas with anaesthetic, analgesic and dissociative/euphoriant effects. Its main psychoactive and anaesthetic action is non-competitive antagonism of the NMDA glutamate receptor, the same channel-blocking mechanism as ketamine, which produces the dissociation, analgesia and anaesthesia. It also releases endogenous opioid peptides (contributing to pain relief) and modulates GABA-A, glycine and two-pore (TREK) potassium channels. The subjective effect comes on within seconds of inhalation and fades within a minute or two, because the gas enters and leaves the brain extremely quickly. It is essentially not metabolised and is exhaled unchanged. This ultra-short action is why recreational users redose repeatedly from balloons. Uniquely among common drugs, nitrous oxide is chemically reactive with vitamin B12: it irreversibly oxidises the cobalt atom of cobalamin and thereby inactivates the B12-dependent enzyme methionine synthase. Occasional use is inconsequential, but heavy or frequent use functionally depletes B12 and can cause subacute combined degeneration of the spinal cord and a peripheral neuropathy: numbness, tingling, weakness and unsteadiness that can become permanent.
Biological targets
- NMDA
Binding & functional measurements
Pharmacokinetics
| Bioavailability | Inhalational, rapid alveolar uptake |
| Tmax | Seconds to minutes |
| Half-life | Very short, cleared within minutes of cessation |
| Vd | Not reported |
| Protein binding | Not reported |
| Metabolism | Essentially not metabolized |
| Excretion | Eliminated unchanged via the lungs |
Toxicology & Safety
Not reported
The commonest acute cause of death with nitrous oxide is not the gas itself but oxygen deprivation: inhaling pure N₂O, especially from a mask, a bag over the head, or in a sealed car or small room, displaces oxygen and can cause hypoxia, loss of consciousness and death by asphyxia. Direct inhalation straight from a pressurised cartridge or tank can also cause cold (frostbite) injury to the lips, airway and lungs, and rapid pressure changes can rarely rupture lung tissue. The distinctive longer-term harm is neurological: because N₂O inactivates vitamin B12, heavy or frequent use causes B12-functional deficiency with subacute combined degeneration of the spinal cord and peripheral neuropathy: tingling, numbness, weakness and difficulty walking that may not fully recover. Falls and injuries occur from the sudden loss of coordination and consciousness, and dependence with very heavy daily use is increasingly reported. Harm reduction: never use a mask or an enclosed space, sit down, use one balloon (never straight from the tank) at a time, keep use occasional, and maintain vitamin-B12 intake.[3][4]
Legal Status
US: Legal (restricted). UK: Class C (2023). DE: Regulated (NpSG, 2026)
Interactions & Contraindications
Drug interactions
Contraindications
No interactions or contraindications listed.
Usage & Context
- A long-established medical gas: an adjunct in general anaesthesia, a sedative in dentistry, and, as a 50:50 mix with oxygen (Entonox/'gas and air'), an analgesic in labour and emergency care.
- Widely used recreationally for its brief euphoria and giddiness, inhaled from balloons filled from small 'whippit'/'nang' cream chargers or, increasingly, large catering tanks.
- Also an industrial and culinary product (whipped-cream propellant, rocket/engine oxidiser) and a significant greenhouse gas.
Sources & Evidence
- PubChem: Nitrous oxide (CID 948) — identifiers & experimental properties
- FDA / DailyMed: Nitrous oxide prescribing information — pharmacokinetics & metabolism
- Garakani A, Jaffe RJ, Savla D, et al. (2016). Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature. Am J Addict 25:358-69.
PMID 27037733 · doi:10.1111/ajad.12372
- Wikipedia: Nitrous oxide — NMDA antagonism, endogenous-opioid/GABA actions, vitamin-B12 inactivation, medical/recreational use & legal status CC BY-SA 4.0
- legislation.gov.uk: Misuse of Drugs Act 1971 (Amendment) Order 2023 — nitrous oxide reclassified as Class C OGL v3.0